✦ LIBER ✦

ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

✍ Scribed by Grosjean-Raillard, J; Tailler, M; Adès, L; Perfettini, J-L; Fabre, C; Braun, T; De Botton, S; Fenaux, P; Kroemer, G

Book ID: 109970790
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 347 KB
Volume: 28
Category: Article
ISSN: 0950-9232
DOI: 10.1038/onc.2008.457

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Flt3 receptor inhibition reduces constit

Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

✍ Jennifer Grosjean-Raillard; Lionel Adès; Simone Boehrer; Maximilien Tailler; Cla 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 699 KB

Arsenic trioxide represses constitutive

Arsenic trioxide represses constitutive activation of NF-κB and COX-2 expression in human acute myeloid leukemia, HL-60

✍ Seong-Su Han; Kihyun Kim; Eun-Ryeong Hahm; Chan H. Park; Bruce F. Kimler; Sook J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 1 views

## Abstract It has been proposed that eukaryotic nuclear factor nuclear factor kappa‐B (NF‐κB) and cyclooxygenase‐2 (COX‐2) are implicated in the pathogenesis of many human diseases including cancer. Arsenic has been widely used in medicine in Oriental countries. Recent studies have shown that arse

L-ascorbic acid represses constitutive a

L-ascorbic acid represses constitutive activation of NF-κB and COX-2 expression in human acute myeloid leukemia, HL-60

✍ Seong-Su Han; Kihyun Kim; Eun-Ryeong Hahm; Sook J. Lee; Young-Joon Surh; Hye K. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB 👁 1 views

## Abstract There is increasing evidence that l‐ascorbic acid (LAA) is selectively toxic to some types of cancer cells at pharmacological concentrations, functioning as a pro‐oxidant rather than as an anti‐oxidant. However, the molecular mechanisms by which LAA initiates cellular signaling leading

The prognostic significance of cytokine

The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes

✍ Apostolia Maria Tsimberidou; Elihu Estey; Sijin Wen; Sherry Pierce; Hagop Kantar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

Acute pulmonary failure during remission

Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome

✍ Ali Al Ameri; Charles Koller; Hagop Kantarjian; Farhad Ravandi; Srdan Verstovsek 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

Results of imatinib mesylate therapy in

Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders

✍ Jorge Cortes; Francis Giles; Susan O'Brien; Deborah Thomas; Maher Albitar; Mary 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## BACKGROUND Imatinib mesylate is a selective tyrosine kinase inhibitor of c‐abl, bcr/abl, c‐kit, and platelet‐derived growth factor‐receptor (PDGF‐R). c‐kit is expressed in most patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) and PDGF has been implicated